Nabriva Therapeutics
NBRV
$1.42
Share price
0.00%
Change (1 day)
-71.20%
Change (1 year)
Categories
Nabriva Therapeutics (NBRV) - Cash on Hand
Cash on Hand as of March 2023 : $1.79 M
According to Nabriva Therapeutics
's latest financial reports the company has $1.79 M in cash and cash equivalents.
A company’s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.
Nabriva Therapeutics - Cash on Hand chart (from 2014 to 2023)
Cash on Hand by year
| Year | Cash on Hand | Change |
|---|---|---|
| 2022-12-31 | $12.41 M | -73.96% |
| 2021-12-31 | $47.67 M | 15.23% |
| 2020-12-31 | $41.37 M | -52% |
| 2019-12-31 | $86.19 M | -15.68% |
| 2018-12-31 | $0.10 B | 17.67% |
| 2017-12-31 | $86.87 M | 3.57% |
| 2016-12-31 | $83.88 M | -25.04% |
| 2015-12-31 | $0.11 B | 5099.52% |
| 2014-12-31 | $2.15 M | -52.64% |
| 2013-12-31 | $4.54 M |
Cash on Hand for similar companies or competitors
| Company | Cash on Hand | differencediff. | Country |
|---|---|---|---|
 ORIC Pharmaceuticals
ORIC | $0.20 B | 11,478.81% | 🇺🇸 USA |